Why are paediatric and geriatric patients considered 'special populations' in pharmacy?

They have unique physiological characteristics (e.g., organ function, body composition) that significantly alter drug pharmacokinetics and pharmacodynamics, leading to different dosing requirements and increased risk of adverse drug reactions compared to adults.

What is polypharmacy and why is it a concern in geriatric patients?

Polypharmacy is the concurrent use of multiple medications, often five or more. In geriatrics, it increases the risk of drug-drug interactions, adverse drug reactions, prescribing cascades, and reduced adherence due to complex regimens.

How do you calculate drug doses for paediatric patients?

Doses are primarily calculated based on body weight (mg/kg) or body surface area (mg/m²), rather than fixed adult doses, to account for their developing physiology and varying sizes.

What are the Beers Criteria and STOPP/START criteria, and why are they relevant to geriatric pharmacy?

The Beers Criteria (USA) and STOPP/START criteria (Europe, including Ireland) are explicit tools used to identify potentially inappropriate medications (PIMs) and prescribing omissions in older adults, aiming to improve medication safety and efficacy.

What are common challenges in medication adherence for older adults?

Challenges include cognitive impairment, multiple medications/complex regimens, physical limitations (e.g., opening bottles), financial constraints, lack of understanding, and forgetfulness.

How does altered renal function impact drug dosing in the elderly?

Decreased renal function is common in the elderly, leading to reduced drug clearance and accumulation of renally excreted drugs. Doses often need to be reduced or intervals extended to prevent toxicity.

What specific formulation considerations are important for paediatric patients?

Paediatric formulations should be palatable, easy to administer (e.g., liquids, chewable tablets), and accurately dosed. Crushing tablets or opening capsules should only be done if validated and appropriate.

What is 'deprescribing' and when should it be considered?

Deprescribing is the systematic process of identifying and discontinuing medications where the potential harms outweigh the potential benefits, especially in older adults with polypharmacy or limited life expectancy. It should be considered when goals of care change, side effects are significant, or a medication is no longer indicated.

Mastering Paediatric & Geriatric Pharmacy for the PSI Registration Exam Part 2: Practice of Pharmacy Examination

Paediatric & Geriatric Pharmacy Considerations for the PSI Registration Exam Part 2

As an aspiring registered pharmacist in Ireland, your ability to provide safe and effective care extends across the entire lifespan. The Complete PSI Registration Exam Part 2: Practice of Pharmacy Examination Guide highlights the critical importance of understanding the unique physiological and pharmacological considerations for vulnerable patient populations. Paediatric and geriatric patients, at opposite ends of the age spectrum, present distinct challenges and require specialised knowledge to ensure optimal medication management. This mini-article, current as of April 2026, delves into these vital areas, outlining why they are central to the PSI Registration Exam Part 2 and how you can master them.

Introduction: Why Age Matters in Pharmacy Practice

The practice of pharmacy is not a one-size-fits-all discipline. Children and older adults are not simply "small adults" or "aged adults"; they possess unique physiological characteristics that profoundly impact how medications are absorbed, distributed, metabolised, and excreted (pharmacokinetics), as well as how they interact with the body to produce an effect (pharmacodynamics). These differences mean that standard adult dosing and treatment guidelines are often inappropriate and potentially dangerous for these special populations.

For the PSI Registration Exam Part 2, examiners expect you to demonstrate a comprehensive understanding of these nuances. Questions will test your ability to apply age-appropriate knowledge to clinical scenarios, ensuring patient safety and optimising therapeutic outcomes. Mastery of this topic is not just about passing an exam; it's fundamental to your professional responsibility as a pharmacist in Ireland.

Key Concepts: Detailed Explanations with Examples

Understanding the core principles for both paediatric and geriatric patients is crucial. While their needs differ, the underlying principle remains the same: tailoring pharmaceutical care to individual physiological realities.

Paediatric Pharmacy Considerations

Children, from neonates to adolescents, are a heterogeneous group with rapidly changing physiology. Their developing organ systems mean that drug handling can vary significantly with age.

Pharmacokinetics (PK) Alterations:
- Absorption: Gastric pH is higher in neonates, affecting absorption of pH-dependent drugs. Gastric emptying is slower initially, then faster in infants. Topical absorption is greater due to thinner skin and higher surface area to volume ratio.
- Distribution: Higher total body water, lower body fat, and immature blood-brain barrier in neonates/infants affect drug distribution, potentially requiring higher loading doses for water-soluble drugs. Reduced plasma protein binding in neonates can increase free drug concentrations for highly protein-bound drugs.
- Metabolism: Hepatic enzyme systems (e.g., CYP450) are immature at birth and mature at different rates. Some enzymes are deficient, while others may be more active than in adults at certain ages. This impacts drug clearance (e.g., paracetamol metabolism, which relies on glucuronidation, is less efficient in neonates).
- Excretion: Renal function (glomerular filtration, tubular secretion, reabsorption) is immature in neonates and young infants, reaching adult levels by around 6-12 months of age. This means renally excreted drugs will have a longer half-life and require dose adjustments.
Pharmacodynamics (PD) Alterations: Receptor sensitivity and density can differ in children, leading to varied responses. For example, infants may be more sensitive to CNS depressants.
Dosing Calculations: Primarily based on body weight (mg/kg) or body surface area (mg/m²), not fixed adult doses. It's vital to use appropriate formulations and measuring devices for accuracy.
Formulation Challenges: Tablets are often difficult for young children to swallow. Liquid formulations must be palatable, stable, and accurately measurable. Off-label use of adult formulations requires careful consideration and sometimes compounding.
Adherence: Ensuring children take their medication involves effective communication with parents/guardians, explaining the importance, dosing, administration technique, and potential side effects.
Safety: High risk of medication errors due to complex calculations and small doses. Special vigilance is required for drugs with narrow therapeutic indices.

Geriatric Pharmacy Considerations

Older adults (typically ≥65 years) often present with multiple comorbidities, polypharmacy, and age-related physiological decline, increasing their susceptibility to adverse drug reactions (ADRs).

Pharmacokinetics (PK) Alterations:
- Absorption: Generally little change, but altered gastric pH, motility, and blood flow can affect some drugs.
- Distribution: Decreased total body water and lean body mass, increased body fat. This leads to higher concentrations of water-soluble drugs and prolonged half-lives for lipid-soluble drugs. Decreased albumin can increase free drug concentrations for highly protein-bound drugs.
- Metabolism: Hepatic blood flow and enzyme activity (especially Phase I reactions like oxidation) can decrease, prolonging drug half-lives.
- Excretion: Renal function declines with age, even in the absence of renal disease. Creatinine clearance (CrCl) should be estimated (e.g., Cockcroft-Gault equation) and used to adjust doses of renally excreted drugs, as serum creatinine may not accurately reflect renal function due to reduced muscle mass.
Pharmacodynamics (PD) Alterations: Altered receptor sensitivity (e.g., increased sensitivity to benzodiazepines and anticholinergics, decreased sensitivity to beta-agonists), reduced homeostatic reserves.
Polypharmacy and Prescribing Cascade: Common issues. Polypharmacy increases the risk of drug-drug interactions (DDIs), ADRs, and non-adherence. A prescribing cascade occurs when a new drug is prescribed to treat an ADR of an existing drug, mistaking the ADR for a new medical condition.
Potentially Inappropriate Medications (PIMs): Tools like the STOPP/START criteria (Screening Tool of Older Person's Prescriptions / Screening Tool to Alert doctors to Right Treatment) are essential for identifying PIMs and prescribing omissions in older adults. These are widely endorsed in Ireland and Europe.
Adherence: Challenges include cognitive impairment, multiple medications, complex regimens, physical limitations, financial issues, and lack of clear instructions.
Deprescribing: The systematic process of identifying and discontinuing medications where the potential harms outweigh the potential benefits, especially in older adults with polypharmacy or limited life expectancy.
Adverse Drug Reactions (ADRs): Older adults are at higher risk for ADRs due to altered PK/PD, polypharmacy, and comorbidities. ADRs often present atypically (e.g., confusion instead of rash).

How It Appears on the Exam: Question Styles and Scenarios

The PSI Registration Exam Part 2 will test your practical application of these concepts. Expect questions that require critical thinking and clinical judgment, often presented as case studies or multiple-choice questions (MCQs). To get a feel for the types of questions, you can explore PSI Registration Exam Part 2: Practice of Pharmacy Examination practice questions.

Common scenarios you might encounter include:

Paediatric Scenarios:
- Calculating a drug dose for an infant based on weight and recommending an appropriate formulation.
- Identifying potential drug interactions or contraindications in a child with multiple conditions (e.g., asthma and ADHD).
- Counselling parents on the safe administration and storage of medication, including what to do in case of a missed dose or side effect.
- Discussing the ethical implications of off-label prescribing in children.
Geriatric Scenarios:
- Reviewing a patient's medication list for polypharmacy, PIMs (using STOPP/START criteria), and potential drug interactions.
- Adjusting drug doses for impaired renal or hepatic function in an elderly patient.
- Identifying and managing an ADR in an older adult, distinguishing it from a new medical condition.
- Counselling an older adult or their caregiver on medication adherence strategies, including the use of compliance aids.
- Suggesting deprescribing opportunities for a patient nearing end-of-life care.
General Scenarios: Questions might compare or contrast aspects of medication use in both populations, or require you to apply principles of patient safety common to both.

Study Tips: Efficient Approaches for Mastering This Topic

Effective preparation is key to success. Here are some strategies for mastering paediatric and geriatric pharmacy for the PSI exam:

Understand the Physiology: Don't just memorise facts; understand *why* drug handling differs. Focus on organ development in children and organ decline in the elderly.
Master Dosing Calculations: Practice paediatric dose calculations (mg/kg, mg/m²) regularly. For geriatrics, focus on renal dose adjustments using estimated CrCl. Be precise and double-check your work.
Familiarise Yourself with Guidelines: Know the STOPP/START criteria inside out. Understand their application and be able to identify inappropriate prescribing based on these guidelines.
Focus on High-Risk Drugs: Identify medications that are particularly problematic in children (e.g., opioids, benzodiazepines, certain antibiotics) and in the elderly (e.g., anticholinergics, NSAIDs, hypnotics, anticoagulants, diuretics). Understand their specific risks in these populations.
Case Study Practice: Work through as many clinical case studies as possible. This helps you apply theoretical knowledge to real-world scenarios. Look for free practice questions that simulate exam conditions.
Learn Communication Strategies: Think about how you would counsel parents/guardians and older adults/caregivers. What language would you use? What information is crucial?
Create Summary Tables: For each population, create tables outlining key PK/PD differences, common problems, and specific management strategies.

Common Mistakes: What to Watch Out For

Avoid these pitfalls to maximise your score on the PSI Registration Exam Part 2:

Applying Adult Doses to Children: This is a critical safety error. Always assume paediatric patients require specific, weight- or BSA-based dosing unless explicitly stated otherwise for a particular drug/age group.
Ignoring Renal/Hepatic Impairment in the Elderly: Failing to consider age-related decline in organ function for dose adjustments can lead to toxicity. Always estimate CrCl.
Overlooking Polypharmacy and Drug Interactions: Not systematically reviewing medication lists for potential interactions, prescribing cascades, or PIMs in older adults.
Poor Communication: Providing generic counselling that doesn't account for the specific needs of parents or older patients (e.g., assuming literacy, cognitive ability, or physical dexterity).
Misinterpreting ADRs as New Conditions: Especially in the elderly, where ADRs can present atypically and lead to a prescribing cascade if not correctly identified.
Not Considering Formulations: Recommending a tablet for an infant or a complex regimen for an elderly patient with cognitive impairment without considering practical administration.

Quick Review / Summary

Paediatric and geriatric pharmacy are indispensable components of the PSI Registration Exam Part 2, reflecting their high-risk nature in everyday practice. Here’s a concise recap:

Paediatrics: Focus on age-related physiological development impacting PK/PD. Dosing is weight/BSA-based. Prioritise appropriate formulations, accurate administration, and effective parent counselling.
Geriatrics: Emphasise age-related organ decline, polypharmacy, and increased ADR risk. Utilise tools like STOPP/START criteria for medication review, adjust doses for renal impairment, and consider deprescribing.
Exam Focus: Expect clinical scenarios requiring dose calculations, identification of inappropriate prescribing, DDI management, and patient counselling strategies tailored to age.
Preparation: Understand underlying physiology, practice calculations, apply guidelines (STOPP/START), and work through case studies.
Patient Safety: The overarching theme for both populations is patient safety – ensuring the right drug, at the right dose, for the right patient, with appropriate monitoring and counselling.

By diligently preparing for these considerations, you will not only excel in your PSI Registration Exam Part 2 but also lay a strong foundation for a career dedicated to safe and effective patient care across all ages.